Comparative efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia

@article{Gentile2000ComparativeES,
  title={Comparative efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia},
  author={S. Gentile and S. Turco and G. Guarino and C. F. Sasso and M. Amodio and P. Magliano and T. Salvatore and G. Corigliano and M. Agrusta and G. de Simone and I. Gaeta and B. Oliviero and R. Torella},
  journal={Diabetes},
  year={2000},
  volume={2}
}
  • S. Gentile, S. Turco, +10 authors R. Torella
  • Published 2000
  • Medicine
  • Diabetes
  • Although there is little information from primary or secondary prevention trials on cholesterol‐lowering medication in diabetic patients, the reduction of elevated cholesterol is widely recommended for this group. The American Diabetes Association (ADA) recommends drug therapy in diabetic patients if low density lipoprotein (LDL)‐cholesterol remains at > 130 mg/dl, or > 100 mg/dl in patients with macroangiopathy, after dietary intervention. When cholesterol‐lowering medication is indicated, the… CONTINUE READING
    52 Citations
    Atorvastatin
    Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control.
    • F. Hobbs
    • Medicine
    • International journal of cardiology
    • 2006
    • 22

    References

    SHOWING 1-10 OF 64 REFERENCES
    Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus.
    • 164